SCHEMBL18540940

SCHEMBL18540940

CCOC(=O)[C@@H]1CN(c2ccc([N+](=O)[O-])c(C)c2)[C@@H](C)O1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.47
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
MAPT P10636 5/20 0.45
HPGD P15428 1/20 0.42
HTT P42858 2/20 0.40
USP2 O75604 1/20 0.40
POLB P06746 1/20 0.40
THRB P10828 1/20 0.40
S100A4 P26447 1/20 0.40
RECQL P46063 1/20 0.40
LMNA P02545 1/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
VCAM1 P19320 1/20 0.38
TP53 P04637 1/20 0.38
KDM4E B2RXH2 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18540942 0.90 ALDH1A1 (0.44) ALDH1A1KMT2AMEN1L3MBTL1MAPT
SCHEMBL18540944 0.87 SIRT6 (0.44) ALDH1A1KMT2AMEN1L3MBTL1MAPT
SCHEMBL18527744 0.86 ALDH1A1 (0.43) ALDH1A1KMT2AMEN1L3MBTL1MAPT
SCHEMBL18540941 0.85 HPGD (0.49) ALDH1A1KMT2AMEN1L3MBTL1MAPT
SCHEMBL18540946 0.82 HPGD (0.49) ALDH1A1KMT2AMEN1L3MBTL1MAPT
SCHEMBL18540930 0.82 HPGD (0.49) ALDH1A1KMT2AMEN1L3MBTL1MAPT
SCHEMBL18540928 0.80 HPGD (0.47) ALDH1A1KMT2AMEN1L3MBTL1MAPT
SCHEMBL18540952 0.80 HPGD (0.47) ALDH1A1KMT2AMEN1L3MBTL1MAPT
SCHEMBL18541069 0.79 ALDH1A1 (0.41) ALDH1A1KMT2AMEN1L3MBTL1MAPT
SCHEMBL16181298 0.77 ALDH1A1 (0.46) ALDH1A1KMT2AMEN1L3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9809583-B2 Oxazolidine-based compound and selective androgen receptor agonist comprising same DONG-A ST CO., LTD. (KR) 2017-11-07 US disclosed
US-20170050955-A1 OXAZOLIDINE-BASED COMPOUND AND SELECTIVE ANDROGEN RECEPTOR AGONIST COMPRISING SAME DONG-A ST CO., LTD. (KR) 2017-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170050955-A1 OXAZOLIDINE-BASED COMPOUND AND SELECTIVE ANDROGEN RECEPTOR AGONIST COMPRISING SAME AR, SHBG, MUSK ALDH1A1 1632/4885KMT2A 1300/4885MEN1 3697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.